Lazard Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $584K | Sell |
|
|||||
|
2025
Q2 | $528K | Sell |
|
|||||
|
2025
Q1 | $2.28M | Sell |
|
|||||
|
2024
Q4 | $1.01M | Buy |
|
|||||
|
2024
Q3 | $859K | Sell |
|
|||||
|
2024
Q2 | $605K | Sell |
|
|||||
|
2024
Q1 | $516K | Sell |
|
|||||
|
2023
Q4 | $702K | Sell |
|
|||||
|
2023
Q3 | $773K | Buy |
|
|||||
|
2023
Q2 | $28K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $53K | Buy |
|
|||||
|
2022
Q3 | $59K | Sell |
|
|||||
|
2022
Q2 | $60K | Buy |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $66K | Sell |
|
|||||
|
2021
Q3 | $1.27M | Buy |
|
|||||
|
2021
Q2 | $72K | Hold |
|
|||||
|
2021
Q1 | $78K | Hold |
|
|||||
|
2020
Q4 | $86K | Sell |
|
|||||
|
2020
Q3 | $70K | Buy |
|
|||||
|
2020
Q2 | $30K | Sell |
|
|||||
|
2020
Q1 | $52K | Buy |
|
|||||
|
2019
Q4 | $3K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $314K | Buy |
|